angiotensin ii has been researched along with Diabetic Retinopathy in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.87) | 18.7374 |
| 1990's | 7 (15.22) | 18.2507 |
| 2000's | 22 (47.83) | 29.6817 |
| 2010's | 11 (23.91) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Capozzi, ME; Padovani-Claudio, DA; Penn, JS; Ramos, CJ | 1 |
| Dixon, MA; Fletcher, EL; Greferath, U; Jobling, AI; Phipps, JA; Vessey, KA; Wang, AY | 1 |
| Allingham, MJ; Deliyanti, D; Jerome, JR; Suphapimol, V; Wilkinson-Berka, JL | 1 |
| Behl, T; Kotwani, A | 1 |
| Ahmad, S; Alhomida, AS; Ferrario, CM; Ola, MS | 1 |
| Cui, ZH; Hao, Q; Li, ZH; Liu, TT; Yang, W; Zhang, Y | 1 |
| Ishii, K; Kurauchi, Y; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Beltramo, E; Carpanetto, A; Iavello, A; Mazzeo, A; Porta, M | 1 |
| Cho, CS; Kim, JH; Kim, KW; Yu, YS | 1 |
| Bursell, SE; Chilcote, TJ; Clermont, AC; Feener, EP; Phipps, JA; Sinha, S | 1 |
| Fletcher, EL; Miller, AG; Wilkinson-Berka, JL | 1 |
| Jin, D; Miyazaki, M; Takai, S | 1 |
| Ban, N; Kubota, S; Kurihara, T; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K | 1 |
| Agrotis, A; Armani, R; Rana, I; Wilkinson-Berka, JL | 1 |
| Funatsu, H; Hori, S; Ikeda, T; Mimura, T; Shimizu, E; Yamashita, H | 1 |
| Moskowitz, DW | 1 |
| Gilbert, RE; Kelly, DJ; Krum, H; Wilkinson-Berka, J | 1 |
| Funatsu, H; Yamashita, H | 1 |
| Funatsu, H; Hori, S; Mimura, T; Noma, H; Sakata, K; Yamashita, H | 1 |
| Xie, XW; Zhao, P | 1 |
| Hiilesmaa, VK; Immonen, IJ; Kaaja, RJ; Loukovaara, S; Nicholls, G; Yandle, TG | 1 |
| Ohashi, H; Takagi, H | 1 |
| Imaizumi, T; Inoue, H; Matsui, T; Nakamura, K; Takeuchi, M; Yamagishi, S | 1 |
| Wilkinson-Berka, JL | 1 |
| Chaturvedi, N; Deinum, J | 1 |
| Inoue, H; Matsui, T; Nakamura, K; Yamagishi, S | 1 |
| Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM | 1 |
| Ito, S; Sugawara, A | 1 |
| Gao, L; Kern, TS; Xi, X; Zhang, JZ | 1 |
| Miller, AG; Wilkinson-Berka, JL | 1 |
| Drury, PL | 1 |
| Christlieb, AR; Gleason, RE; Rand, LI; Rhie, FH; Sandor, T; Shah, ST; Soeldner, JS | 1 |
| Admiraal, PJ; Danser, AH; de Jong, PT; Deinum, J; Derkx, FH; Schalekamp, MA | 1 |
| Leese, GP; Vora, JP | 1 |
| Alder, VA; Cringle, SJ; Su, EN; Yu, DY; Yu, PK | 1 |
| Stoschitzky, K | 1 |
| Williams, B | 2 |
| Beevers, DG; Headon, M; Jones, AF; Lip, GY; Lip, PL; Price, N | 1 |
| Broadbent, DM | 1 |
| Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL | 1 |
| Funatsu, H; Hori, S; Nakanishi, Y; Yamashita, H | 1 |
| Funatsu, H; Hori, S; Ikeda, T; Kitano, S; Nakanishi, Y; Yamashita, H | 1 |
| Aiello, LM; Cabral, BV; Christlieb, AR; Gleason, RE; Icasas-Cabral, EA; Janka, HU; Kraus, B; Solano, A | 1 |
| Caramazza, R; Martelli, AM; Pensabeni, L; Puglioli, R; Rubbi, F; Tabacchi, P; Volanti, S | 1 |
| Danser, AH; de Jong, PT; Deinum, J; Derkx, FH; Franken, AA; Peperkamp, E; Schalekamp, MA; van den Dorpel, MA | 1 |
22 review(s) available for angiotensin ii and Diabetic Retinopathy
| Article | Year |
|---|---|
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
Topics: Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Hyperglycemia; Hypertension; Neuroglia; Palmitic Acid | 2023 |
The renin-angiotensin system and the retinal neurovascular unit: A role in vascular regulation and disease.
Topics: Angiotensin II; Animals; Diabetic Retinopathy; Humans; Microglia; Renin-Angiotensin System; Retinal Vessels | 2019 |
Angiotensin II and aldosterone in retinal vasculopathy and inflammation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetic Retinopathy; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retinal Vessels; Retinitis; Retinopathy of Prematurity; Wet Macular Degeneration | 2019 |
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Diabetic Retinopathy; Humans; Inflammation; Neovascularization, Pathologic; Oxidative Stress; Renin-Angiotensin System | 2017 |
Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Chymases; Diabetic Retinopathy; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2017 |
Neurovascular interactions in the retina: physiological and pathological roles.
Topics: Angiotensin II; Catecholamines; Cell Communication; Diabetic Retinopathy; Disease Progression; Drug Discovery; Endothelin Receptor Antagonists; Endothelin-1; Glaucoma; Homeostasis; Molecular Targeted Therapy; N-Methylaspartate; Neuroglia; Neurons; Nitric Oxide; Nitric Oxide Synthase Type II; Potassium Channels, Calcium-Activated; Receptors, GABA; Retina; Retinal Diseases; Retinal Vessels | 2013 |
Prorenin and the (pro)renin receptor: do they have a pathogenic role in the retina?
Topics: Angiotensin II; Diabetic Retinopathy; Humans; Infant, Newborn; Macular Degeneration; Prorenin Receptor; Receptors, Cell Surface; Renin; Retina; Retinopathy of Prematurity | 2010 |
Chymase as an important target for preventing complications of metabolic syndrome.
Topics: Angiotensin II; Animals; Atherosclerosis; Chymases; Diabetes Complications; Diabetic Retinopathy; Fatty Liver; Humans; Hypertension; Matrix Metalloproteinase 9; Metabolic Syndrome; Mice; Transforming Growth Factor beta | 2010 |
Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model.
Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Mice; Models, Neurological; Nerve Degeneration; Oxidative Stress; Rats; Reactive Oxygen Species; Renin-Angiotensin System; Retinal Degeneration; Signal Transduction | 2011 |
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Topics: Angiotensin II; Animals; Diabetic Retinopathy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infant, Newborn; Infant, Premature; Inflammation; Membrane Glycoproteins; Models, Animal; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Pathologic; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Retina; Retinopathy of Prematurity | 2013 |
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetes.
Topics: Aging; Angiotensin II; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Heart Diseases; Humans; Insulin Resistance; Mechanoreceptors; Peptidyl-Dipeptidase A | 2003 |
The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Growth Substances; Humans; Renin-Angiotensin System | 2003 |
Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetic Retinopathy; Disease Progression; Humans; Hyperglycemia; Hypertension; Macular Degeneration; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Vascular Endothelial Growth Factors | 2003 |
[The Diabetic Retinopathy Candesartan Trials (DIRECT) programme].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Renin-Angiotensin System; Retina; Risk Factors; Tetrazoles; Vascular Endothelial Growth Factor A | 2005 |
Angiotensin and diabetic retinopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Diabetic Retinopathy; Humans; Hypertension; Neovascularization, Pathologic; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Retina | 2006 |
The Renin-Angiotensin system and vascular disease in diabetes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Renin-Angiotensin System | 2002 |
[Stimulatory effects of angiotensin II on angiogenesis].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Tetrazoles; Vascular Endothelial Growth Factor A | 2006 |
Update on the treatment of diabetic retinopathy.
Topics: Adrenal Cortex Hormones; Aldehyde Reductase; Angiotensin II; Antihypertensive Agents; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dyslipidemias; Enzyme Inhibitors; Glycation End Products, Advanced; Human Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insulin; Laser Coagulation; Protein Kinase C; Vascular Endothelial Growth Factor A; Vitamin E | 2008 |
Diabetes and arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases | 1983 |
The management of hypertension in diabetes: with special reference to diabetic kidney disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Glomerular Filtration Rate; Hypertension | 1996 |
A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
Topics: Angiotensin II; Animals; Diabetic Nephropathies; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Kidney; Lymphokines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Diabetic eye disease: how can it be prevented?
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Retinopathy; Humans; Hyperglycemia; Laser Therapy; Risk Factors | 2000 |
1 trial(s) available for angiotensin ii and Diabetic Retinopathy
| Article | Year |
|---|---|
Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects.
Topics: Angiotensin II; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Retinopathy; Dose-Response Relationship, Drug; Humans; Norepinephrine; Renin | 1976 |
23 other study(ies) available for angiotensin ii and Diabetic Retinopathy
| Article | Year |
|---|---|
Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Flow Cytometry; Gene Expression Regulation; Immunohistochemistry; Male; MAP Kinase Signaling System; MicroRNAs; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA; Signal Transduction | 2018 |
Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy.
Topics: Angiotensin II; Cells, Cultured; Diabetic Retinopathy; Extracellular Vesicles; Humans; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; Pericytes; Platelet-Derived Growth Factor; Retinal Vessels; Signal Transduction | 2015 |
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Capillary Permeability; Cell Line; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Fluoresceins; Humans; Mice; Mice, Inbred C57BL; Perindopril; Retina; Tight Junctions; Vascular Endothelial Growth Factor A | 2009 |
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Hypertension; Kallikreins; Kinins; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Artery; Streptozocin; Tetrazoles | 2009 |
Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
Topics: Aged; Angiotensin II; Case-Control Studies; Diabetic Retinopathy; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Edema; Male; Radioimmunoassay; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitrectomy; Vitreous Body; Vitreous Detachment | 2003 |
Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
Topics: Adult; Aged; Angiotensin II; Diabetic Retinopathy; Disease Progression; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2004 |
[The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Mice; Random Allocation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2004 |
Vasoactive mediators and retinopathy during type 1 diabetic pregnancy.
Topics: Adrenomedullin; Adult; Aldosterone; Angiotensin II; Blood Flow Velocity; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Natriuretic Peptides; Peptides; Pregnancy; Pregnancy in Diabetics; Renin; Renin-Angiotensin System; Retinal Vessels; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Cells, Cultured; Diabetic Retinopathy; Glycation End Products, Advanced; NF-kappa B; Pericytes; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptor, Angiotensin, Type 1; Receptors, Immunologic; Retina; RNA, Messenger; Telmisartan; Up-Regulation | 2005 |
Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
Topics: Adult; Angiotensin II; Antibodies, Blocking; Cell Survival; Cells, Cultured; Coculture Techniques; Diabetic Retinopathy; Down-Regulation; Endothelium, Vascular; Eye Proteins; Growth Inhibitors; Humans; Microcirculation; Mitogens; Nerve Growth Factors; Pericytes; RNA, Messenger; Serpins | 2005 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases | 2006 |
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1 | 2007 |
Retinal vascular reactivity to norepinephrine and angiotensin II in normals and diabetics.
Topics: Adult; Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Male; Norepinephrine; Retinal Artery; Vasoconstriction | 1982 |
Angiotensin levels in the eye.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Animals; Blood-Retinal Barrier; Child; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Eye; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Peptidyl-Dipeptidase A; Rabbits; Renin-Angiotensin System; Swine | 1994 |
Altered vasoactivity in the early diabetic eye: measured in the isolated perfused rat eye.
Topics: Angiotensin II; Animals; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dinoprost; Eye; Isoproterenol; Male; Optic Nerve; Phenylephrine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin; Vascular Resistance; Vasoconstrictor Agents | 1995 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Lisinopril; Research Design | 1998 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Lisinopril; Lymphokines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?
Topics: Aged; Angiotensin I; Angiotensin II; Aqueous Humor; Blood Pressure; Cell Division; Cross-Sectional Studies; Diabetic Retinopathy; Endothelium, Vascular; Female; Hemorheology; Humans; Lipoprotein(a); Male; Neovascularization, Pathologic; P-Selectin; Retinal Neovascularization; Retinal Vessels; Thrombosis | 1998 |
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Topics: Angiotensin II; Diabetic Retinopathy; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphokines; Male; Middle Aged; Peptidyl-Dipeptidase A; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitreous Body | 2002 |
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.
Topics: Aged; Angiotensin II; Blood-Retinal Barrier; Capillary Permeability; Case-Control Studies; Diabetic Retinopathy; Endothelial Growth Factors; Female; Humans; Lymphokines; Macular Edema; Male; Middle Aged; Radioimmunoassay; Severity of Illness Index; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitreous Body | 2002 |
[Determination of serum angiotensin II in proliferative diabetic retinopathy].
Topics: Adult; Angiotensin II; Diabetic Retinopathy; Humans; Middle Aged; Radioimmunoassay | 1989 |
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Diabetic Retinopathy; Enzyme Precursors; Female; Humans; Male; Middle Aged; Radioimmunoassay; Renin; Vitreous Body | 1989 |